Skip to main content
SpringerLink
Log in

Comment on: A Framework for the Fair Pricing of Medicines

  • Letter to the Editor
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 13 March 2024

The Original Article was published on 08 December 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

References

  1. Paulden M. A framework for the fair pricing of medicines. Pharmacoeconomics. 2024;42(2):145–64. https://doi.org/10.1007/s40273-023-01325-z.

    Article  PubMed  Google Scholar 

  2. Pani L, Montilla S, Németh G, Russo P, Viceconte G, Vogler S. Balancing access to medicines and sustainability in Europe: an analysis from the network of competent authorities on pricing and reimbursement (CAPR). Pharmacol Res. 2016;111:247–50.

    Article  PubMed  Google Scholar 

  3. Maxwell S. Fair price: research outside marketing. J Prod Brand Manag. 2008;17:497–503. https://doi.org/10.1108/10610420810916399.

    Article  Google Scholar 

  4. Bolton LE, Warlop L, Alba JW. Consumer perceptions of price (un)fairness. J Consum Res. 2003;29:474–91. https://doi.org/10.1086/346244.

    Article  Google Scholar 

  5. Hou L. Excessive prices within EU competition law. Eur Compet J. 2011;7:47-70. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=1850569doi:10.5235/174410511795887606. Accessed 6 Mar 2024

  6. Moon S, Mariat S, Kamae I, Pedersen HB. Defining the concept of fair pricing for medicines. BMJ. 2020;13(368): l4726. https://doi.org/10.1136/bmj.l4726.

    Article  Google Scholar 

  7. Rickard E, Ozieranski P. A hidden web of policy influence: the pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups. PLoS One. 2021;16(6): e0252551.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Associate Minister of Health, Minister of Health. Medicines New Zealand: Contributing to good health outcomes for all New Zealanders. Wellington. 2007. https://www.health.govt.nz/system/files/documents/publications/medicines-nz.pdf. Accessed 6 Mar 2024

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacy, University of Huddersfield, Huddersfield, UK

    Zaheer-Ud-Din Babar

Authors
  1. Zaheer-Ud-Din Babar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zaheer-Ud-Din Babar.

Ethics declarations

Funding

No sources of funding were used to assist in the preparation of this letter.

Conflicts of interest

Zaheer-Ud-Din Babar has no conflicts of interest to declare in relation to this work.

Author’s contributions

ZB conceptualised and wrote this letter.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Babar, ZUD. Comment on: A Framework for the Fair Pricing of Medicines. PharmacoEconomics 42, 605–606 (2024). https://doi.org/10.1007/s40273-024-01368-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-024-01368-w

Search

Navigation